Microarray testing in patients with systemic lupus erythematosus identifies a high prevalence of CpG DNA-binding antibodies.
Tammo E BrunekreefMaarten LimperRowena MelchersLinda Mathsson-AlmJorge DiasImo HoeferSaskia HaitjemaJacob M van LaarHenny OttenPublished in: Lupus science & medicine (2022)
Antibodies against CpG DNA motifs are prevalent in patients with SLE. Anti-CMV antibodies are associated with lupus nephritis.